Latest Regulatory Approval News

Genesis Energy and New Zealand’s top generators are exploring extending Huntly Power Station’s life to address supply risks highlighted by winter 2024’s energy crunch.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.

Koonenberry Gold has initiated a targeted diamond drilling campaign at its Enmore Gold Project in NSW, aiming to expand on historically significant gold mineralisation at the Sunnyside Prospect. This marks the first follow-up drilling since acquisition, with promising intercepts suggesting substantial upside.

Golden Horse Minerals updates its Southern Cross Project exploration with compelling soil geochemistry results revealing extensive gold anomalies and confirms acquisition of the Irene Betty lease, setting the stage for targeted drilling in 2025.

GTI Energy Ltd reports promising uranium leach test results from its Lo Herma project in Wyoming, demonstrating approximately 75% recovery rates consistent with regional ISR operations. These findings underpin the upcoming Scoping Study expected in H1 2025.

E79 Gold Mines has identified promising new drill targets at its Laverton South Project following significant gold mineralisation results from neighbouring Kalgoorlie Gold Mining Ltd. The company plans to initiate aircore drilling in the March Quarter to test these high-potential zones.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

Mantle Minerals Limited has announced a significant 10-for-1 consolidation of its ordinary shares and performance rights, set to reshape its capital structure by March 2025. This move aims to streamline the company’s share register ahead of renewed market activity.

Foresta Group Holdings has signed a non-binding term sheet with Genesis Energy to supply torrefied wood pellets for Huntly Power Station, marking a pivotal step toward reducing New Zealand’s coal dependency by 2028.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.

TEAMINVEST PRIVATE GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.015 per share for the six months ending December 31, 2024, payable in March 2025.